3-6 December 2016
American Society of Hematology (ASH)
CA
United States
Poster Information: Safety, Phamacokinetics (PK), Pharmacodynamics (PD) and Preliminary Activity in Acute Leukemia of Ory-1001, a First-in-Class Inhibitor of Lysine-Specific Histone Demethylase 1A (LSD1/KDM1A): Initial Results from a First-in-Human Phase 1 Study
Abstract Number: 4060
Session Name: 616. Acute Myeloid Leukemia: Novel Therapy, excluding Transplantation: Poster III
Presentation Date: Monday, December 5, 2016
Presentation Time: 6:00 PM - 8:00 PM PST
Location: Hall GH (San Diego Convention Center)